Work

A phase I extension study of BBI608, a first-in-class cancer stem cell (CSC) inhibitor, in patients with advanced solid tumors.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.2546

Authors: Derek J. Jonker, Joe Stephenson, William Jeffery Edenfield, Jeffrey G. Supko, Youzhi Li, Wei Li, Matthew Hitron, David Leggett, David Kerstein, Chiang Li

Institutions: Ottawa Hospital Research Institute, Massachusetts General Hospital, Boston Biomedical (United States)

Language: English

Topic: Cancer Cells and Metastasis

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2481032118

Cites:

Cited by: 20

Related to: 10